☰

Becky K. Brisson, Ph.D. - Publications

Affiliations: 
2012 Cell and Molecular Biology University of Pennsylvania, Philadelphia, PA, United States 
Area:
Cell Biology, Physiology Biology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Barton ER, Pham J, Brisson BK, Park S, Smith LR, Liu M, Tian Z, Hammers DW, Vassilakos G, Sweeney HL. Functional muscle hypertrophy by increased insulin-like growth factor 1 does not require dysferlin. Muscle & Nerve. PMID 31323135 DOI: 10.1002/Mus.26641  0.722
2014 Brisson BK, Spinazzola J, Park S, Barton ER. Viral expression of insulin-like growth factor I E-peptides increases skeletal muscle mass but at the expense of strength. American Journal of Physiology. Endocrinology and Metabolism. 306: E965-74. PMID 24569593 DOI: 10.1152/Ajpendo.00008.2014  0.736
2014 Park S, Brisson BK, Liu M, Spinazzola JM, Barton ER. Mature IGF-I excels in promoting functional muscle recovery from disuse atrophy compared with pro-IGF-IA. Journal of Applied Physiology (Bethesda, Md. : 1985). 116: 797-806. PMID 24371018 DOI: 10.1152/Japplphysiol.00955.2013  0.741
2013 Brisson BK, Barton ER. New Modulators for IGF-I Activity within IGF-I Processing Products. Frontiers in Endocrinology. 4: 42. PMID 23543904 DOI: 10.3389/Fendo.2013.00042  0.687
2013 Durzy?ska J, Philippou A, Brisson BK, Nguyen-McCarty M, Barton ER. The pro-forms of insulin-like growth factor I (IGF-I) are predominant in skeletal muscle and alter IGF-I receptor activation. Endocrinology. 154: 1215-24. PMID 23407451 DOI: 10.1210/En.2012-1992  0.725
2012 Brisson BK, Barton ER. Insulin-like growth factor-I E-peptide activity is dependent on the IGF-I receptor. Plos One. 7: e45588. PMID 23029120 DOI: 10.1371/Journal.Pone.0045588  0.688
2012 Barton ER, Park S, James JK, Makarewich CA, Philippou A, Eletto D, Lei H, Brisson B, Ostrovsky O, Li Z, Argon Y. Deletion of muscle GRP94 impairs both muscle and body growth by inhibiting local IGF production. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 3691-702. PMID 22649033 DOI: 10.1096/Fj.11-203026  0.723
2010 Wang B, Yang Z, Brisson BK, Feng H, Zhang Z, Welch EM, Peltz SW, Barton ER, Brown RH, Sweeney HL. Membrane blebbing as an assessment of functional rescue of dysferlin-deficient human myotubes via nonsense suppression. Journal of Applied Physiology (Bethesda, Md. : 1985). 109: 901-5. PMID 20558759 DOI: 10.1152/Japplphysiol.01366.2009  0.605
2010 Barton ER, Wang BJ, Brisson BK, Sweeney HL. Diaphragm displays early and progressive functional deficits in dysferlin-deficient mice. Muscle & Nerve. 42: 22-9. PMID 20544921 DOI: 10.1002/Mus.21645  0.641
2010 Barton E, Park S, James J, Brisson B, Philippou A, Dong Y, Haught A, Argon Y. OR4,23 ER chaperone GRP94 depletion in skeletal muscle reduces muscle and organismal growth through inhibition of IGF-I production Growth Hormone & Igf Research. 20: S11. DOI: 10.1016/S1096-6374(10)70031-9  0.662
2009 Pfeffer LA, Brisson BK, Lei H, Barton ER. The insulin-like growth factor (IGF)-I E-peptides modulate cell entry of the mature IGF-I protein. Molecular Biology of the Cell. 20: 3810-7. PMID 19605562 DOI: 10.1091/Mbc.E08-12-1202  0.702
Show low-probability matches.